What are the clinical uses of glutathione administered by injection?

Injectable Glutathione: Clinical Uses

Injectable glutathione has extremely limited evidence-based clinical indications and should generally not be used for systemic therapeutic purposes. The only FDA-approved use is as a component of intraocular irrigating solutions during ophthalmic surgery, not for systemic injection 1.

FDA-Approved Use

Ophthalmic Surgery Only:

• Glutathione is approved solely as part of BSS PLUS™ intraocular irrigating solution (0.184 mg/mL oxidized glutathione)
• Used during eye surgery for irrigation purposes
• Explicitly labeled: "NOT FOR INJECTION OR INTRAVENOUS INFUSION" 1

Off-Label Uses Lacking Evidence

Skin Lightening (Not Recommended)

Despite widespread marketing, IV glutathione for skin lightening has inadequate safety data and no regulatory approval 2. Key concerns include:

• No published studies on IV glutathione specifically for skin lightening
• Potential increased risk of sun-induced skin cancers due to melanin production shift
• Complications from IV infusions
• Only oral and topical formulations have been studied (not IV) with minimal evidence 2

Critical Care/Nutritional Support (Not Recommended for General Use)

The 2019 ESPEN ICU guidelines and 2025 surgical guidelines address glutamine (not glutathione), which are different compounds 3, 4. For glutathione specifically:

• No general recommendation exists for IV glutathione supplementation in surgical or ICU patients
• Evidence is insufficient to support routine use 4

Pharmacokinetic Limitations

IV glutathione has severe pharmacokinetic drawbacks 5, 6:

• Extremely short half-life: 14.1 ± 9.2 minutes
• Rapid elimination rate: 0.063 ± 0.027 min⁻¹
• Creates non-physiological plasma concentrations causing reductive stress
• May impair mitochondrial and immune functions 6
• Effects are transient and not sustainable therapeutically

Safety Concerns

Critical warnings about IV glutathione use 6, 2:

• Reductive stress: High-dose IV administration causes metabolic imbalance opposite to oxidative stress
• No long-term safety studies exist for chronic IV use
• Potential complications from repeated IV access
• Risk of contamination from unregulated online sources
• May cause transient symptom relief that reflects metabolic modulation rather than true therapeutic benefit 6

Unproven Claims

While case reports suggest potential benefit in COVID-19 dyspnea 7, this represents anecdotal evidence only and lacks controlled trial validation. Similarly, claims for anti-aging and tissue regeneration 8, 9 are based on mechanistic rationale rather than clinical efficacy data for injectable formulations.

Clinical Recommendation Algorithm

When considering glutathione therapy:

1. Is this for ophthalmic surgery irrigation?

   • Yes → Use FDA-approved BSS PLUS™ solution 1
   • No → Proceed to step 2

2. Is this for skin lightening or cosmetic purposes?

   • Yes → Do not use IV glutathione - inadequate safety data 2
   • Consider topical formulations only if evidence-based

3. Is this for systemic antioxidant therapy?

   • Do not use IV glutathione - causes reductive stress 6
   • Consider precursor-based supplements (N-acetylcysteine, glycine) that support endogenous synthesis instead 9, 10

4. Is this for critical illness/nutritional support?

   • No general recommendation exists 4
   • Focus on evidence-based nutritional interventions

The safest approach is supporting endogenous glutathione synthesis through dietary precursors and Nrf2-activating compounds rather than direct IV administration 6, 9, 10.